$250 Million GranuFlo Settlement

Fresenius Reaches $250 Million GranuFlo Settlement On February 22, 2016, it was announced that Fresenius Medical Care reached an agreement to set aside $250 million to settle claims stemming from their GranuFlo and Naturalyte dialysis concentrates. GranuFlo and NaturaLyte are medications used on dialysis patients undergoing treatment for kidney disease and renal failure during ...Read the full article